{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:26:10Z","timestamp":1788575170495,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>There is no clear and contemporaneous method for screening of idiopathic hirsutism (IH) and polycystic ovary syndrome (PCOS) at the community level and current estimates regarding their prevalence are limited. We aimed to ascertain the prevalence of IH and PCOS in a randomly selected sample of reproductive aged female participants of the Tehran Lipid and Glucose Study (TLGS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>One thousand and two women, aged 18-45 years, were randomly selected from among reproductive aged women who participated in the TLGS. Those women with either hirsutism or menstrual dysfunction were assessed for biochemical hyperandrogenemia; whereas those participants with hirsutism per se were further assessed for subclinical menstrual dysfunction. PCOS were diagnosed using the National Institute of Health (NIH) criteria. IH was defined as hirsutism without clinical or sub clinical menstrual dysfunction or biochemical hyperandrogenemia (BH).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The mean \u00b1 SD of age of study population was 29.2 \u00b1 8.7 years. Estimated prevalences of idiopathic hirsutism and pure menstrual dysfunction were 13.0% (95% CI: 10.9%-15.1%) and 1.5%(95% CI: 1.1%-1.9%), respectively. The prevalence of PCOS was 8.5% (95% CI: 6.8% - 10.2%); more than one third of these cases would possibly have remained undiagnosed or misdiagnosed, had we not assessed them for subclinical menstrual dysfunction or biochemical hyperandrogenemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These data from a large representative and non selected population of women confirm the concept that IH and PCOS are the two most common gynecological endocrinopathies among reproductive aged women. The estimated prevalence of these conditions is highly influenced by their screening methods at the community level.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7827-9-144","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T20:31:59Z","timestamp":1320179519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study"],"prefix":"10.1186","volume":"9","author":[{"given":"Fahimeh Ramezani","family":"Tehrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homeira","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoun","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,1]]},"reference":[{"key":"920_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1210\/er.21.4.347","volume":"21","author":"R Azziz","year":"2000","unstructured":"Azziz R, Carmina E, Sawaya ME: Idiopathic hirsutism. Endocr Rev. 2000, 21: 347-362. 10.1210\/er.21.4.347.","journal-title":"Endocr Rev"},{"key":"920_CR2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF: The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009, 91: 456-488. 10.1016\/j.fertnstert.2008.06.035.","journal-title":"Fertil Steril"},{"key":"920_CR3","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1210\/jc.85.7.2434","volume":"85","author":"M Asuncion","year":"2000","unstructured":"Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF: A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000, 85: 2434-2438. 10.1210\/jc.85.7.2434.","journal-title":"J Clin Endocrinol Metab"},{"key":"920_CR4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2010","unstructured":"March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ: The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010, 25: 544-551. 10.1093\/humrep\/dep399.","journal-title":"Hum Reprod"},{"key":"920_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1477-7827-9-39","volume":"9","author":"FR Tehrani","year":"2011","unstructured":"Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F: The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol. 2011, 9: 39-10.1186\/1477-7827-9-39.","journal-title":"Reprod Biol Endocrinol"},{"key":"920_CR6","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO: The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004, 89: 2745-2749. 10.1210\/jc.2003-032046.","journal-title":"J Clin Endocrinol Metab"},{"key":"920_CR7","first-page":"238","volume":"62","author":"F Mehrabian","year":"2011","unstructured":"Mehrabian F, Khani B, Kelishadi R, Ghanbari E: The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol. 2011, 62: 238-242.","journal-title":"Endokrynol Pol"},{"key":"920_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejogrb.2007.12.018","volume":"139","author":"X Chen","year":"2008","unstructured":"Chen X, Yang D, Mo Y, Li L, Chen Y, Huang Y: Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstet Gynecol Reprod Biol. 2008, 139: 59-64. 10.1016\/j.ejogrb.2007.12.018.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"920_CR9","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.fertnstert.2005.03.051","volume":"84","author":"MO Goodarzi","year":"2005","unstructured":"Goodarzi MO, Quinones MJ, Azziz R, Rotter JI, Hsueh WA, Yang H: Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance. Fertil Steril. 2005, 84: 766-769. 10.1016\/j.fertnstert.2005.03.051.","journal-title":"Fertil Steril"},{"key":"920_CR10","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1210\/jc.83.9.3078","volume":"83","author":"ES Knochenhauer","year":"1998","unstructured":"Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R: Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998, 83: 3078-3082. 10.1210\/jc.83.9.3078.","journal-title":"J Clin Endocrinol Metab"},{"key":"920_CR11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1046\/j.1365-2265.1999.00886.x","volume":"51","author":"KF Michelmore","year":"1999","unstructured":"Michelmore KF, Balen AH, Dunger DB, Vessey MP: Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf). 1999, 51: 779-786. 10.1046\/j.1365-2265.1999.00886.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"920_CR12","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","volume":"84","author":"E Diamanti-Kandarakis","year":"1999","unstructured":"Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI: A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab. 1999, 84: 4006-4011. 10.1210\/jc.84.11.4006.","journal-title":"J Clin Endocrinol Metab"},{"key":"920_CR13","first-page":"870","volume":"44","author":"L Farah","year":"1999","unstructured":"Farah L, Lazenby AJ, Boots LR, Azziz R: Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group. J Reprod Med. 1999, 44: 870-874.","journal-title":"J Reprod Med"},{"key":"920_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1159\/000277640","volume":"69","author":"C Moran","year":"2010","unstructured":"Moran C, Tena G, Moran S, Ruiz P, Reyna R, Duque X: Prevalence of polycystic ovary syndrome and related disorders in mexican women. Gynecol Obstet Invest. 2010, 69: 274-280. 10.1159\/000277640.","journal-title":"Gynecol Obstet Invest"},{"key":"920_CR15","first-page":"7","volume":"10","author":"H Ansarin","year":"2007","unstructured":"Ansarin H, Aziz-Jalali MH, Rasi A, Soltani-Arabshahi R: Clinical presentation and etiologic factors of hirsutism in premenopausal Iranian women. Arch Iran Med. 2007, 10: 7-13.","journal-title":"Arch Iran Med"},{"key":"920_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0015-0282(98)00141-1","volume":"70","author":"R Azziz","year":"1998","unstructured":"Azziz R, Waggoner WT, Ochoa T, Knochenhauer ES, Boots LR: Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. Fertil Steril. 1998, 70: 274-278. 10.1016\/S0015-0282(98)00141-1.","journal-title":"Fertil Steril"},{"key":"920_CR17","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/00003081-199009000-00028","volume":"33","author":"RL Barbieri","year":"1990","unstructured":"Barbieri RL: Hyperandrogenic disorders. Clin Obstet Gynecol. 1990, 33: 640-654. 10.1097\/00003081-199009000-00028.","journal-title":"Clin Obstet Gynecol"},{"key":"920_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2217\/17455057.4.6.583","volume":"4","author":"CD Christakou","year":"2008","unstructured":"Christakou CD, Diamanti-Kandarakis E: Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome. Womens Health (Lond Engl). 2008, 4: 583-594. 10.2217\/17455057.4.6.583.","journal-title":"Womens Health (Lond Engl)"},{"key":"920_CR19","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3109\/09513590.2010.488776","volume":"5","author":"H Chun-Sen","year":"2011","unstructured":"Chun-Sen H, Chien-Hua W, Wan-Chun C, Ching-Tzu L, Chun-Jen C, Ming IH: Obesity and insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol. 2011, 5: 300-306.","journal-title":"Gynecol Endocrinol"},{"key":"920_CR20","doi-asserted-by":"publisher","first-page":"5454","DOI":"10.1210\/jc.2003-032237","volume":"89","author":"EO Talbott","year":"2004","unstructured":"Talbott EO, Zborowski JV, Rager JR, Boudreaux MY, Edmundowicz DA, Guzick DS: Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004, 89: 5454-5461. 10.1210\/jc.2003-032237.","journal-title":"J Clin Endocrinol Metab"},{"key":"920_CR21","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1111\/j.1471-0528.2009.02347.x","volume":"116","author":"HY Zhang","year":"2009","unstructured":"Zhang HY, Zhu FF, Xiong J, Shi XB, Fu SX: Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population. BJOG. 2009, 116: 1633-1639. 10.1111\/j.1471-0528.2009.02347.x.","journal-title":"BJOG"},{"key":"920_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ijgo.2010.01.014","volume":"109","author":"A El-Mazny","year":"2010","unstructured":"El-Mazny A, Abou-Salem N, El-Sherbiny W: Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome. Int J Gynaecol Obstet. 2010, 109: 239-241. 10.1016\/j.ijgo.2010.01.014.","journal-title":"Int J Gynaecol Obstet"},{"key":"920_CR23","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/j.1365-2133.2009.09078.x","volume":"160","author":"NS Abdel Fattah","year":"2009","unstructured":"Abdel Fattah NS, Darwish YW: Is there a role for insulin resistance in nonobese patients with idiopathic hirsutism?. Br J Dermatol. 2009, 160: 1011-1015. 10.1111\/j.1365-2133.2009.09078.x.","journal-title":"Br J Dermatol"},{"key":"920_CR24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0015-0282(16)57297-5","volume":"63","author":"RJ Norman","year":"1995","unstructured":"Norman RJ, Mahabeer S, Masters S: Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome. Fertil Steril. 1995, 63: 58-62.","journal-title":"Fertil Steril"},{"key":"920_CR25","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diab.42.10.1462","volume":"42","author":"A Dunaif","year":"1993","unstructured":"Dunaif A, Sorbara L, Delson R, Green G: Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women. Diabetes. 1993, 42: 1462-1468. 10.2337\/diabetes.42.10.1462.","journal-title":"Diabetes"},{"key":"920_CR26","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1210\/jc.2004-2301","volume":"91","author":"CM DeUgarte","year":"2006","unstructured":"DeUgarte CM, Woods KS, Bartolucci AA, Azziz R: Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab. 2006, 91: 1345-1350. 10.1210\/jc.2004-2301.","journal-title":"J Clin Endocrinol Metab"},{"key":"920_CR27","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1210\/jcem-72-6-1242","volume":"72","author":"DP Lookingbill","year":"1991","unstructured":"Lookingbill DP, Demers LM, Wang C, Leung A, Rittmaster RS, Santen RJ: Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. J Clin Endocrinol Metab. 1991, 72: 1242-1248. 10.1210\/jcem-72-6-1242.","journal-title":"J Clin Endocrinol Metab"},{"key":"920_CR28","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/aje\/kwn137","volume":"168","author":"V Kumarapeli","year":"2008","unstructured":"Kumarapeli V, Seneviratne Rde A, Wijeyaratne CN, Yapa RM, Dodampahala SH: A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Am J Epidemiol. 2008, 168: 321-328. 10.1093\/aje\/kwn137.","journal-title":"Am J Epidemiol"},{"key":"920_CR29","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.fertnstert.2006.11.149","volume":"88","author":"MI Hsu","year":"2007","unstructured":"Hsu MI, Liou TH, Chou SY, Chang CY, Hsu CS: Diagnostic criteria for polycystic ovary syndrome in Taiwanese Chinese women: comparison between Rotterdam 2003 and NIH 1990. Fertil Steril. 2007, 88: 727-729. 10.1016\/j.fertnstert.2006.11.149.","journal-title":"Fertil Steril"},{"key":"920_CR30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","volume":"140","author":"R Hatch","year":"1981","unstructured":"Hatch R, Rosenfield RL, Kim MH, Tredway D: Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981, 140: 815-830.","journal-title":"Am J Obstet Gynecol"},{"key":"920_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0029-7844(03)00527-1","volume":"102","author":"CE Malcolm","year":"2003","unstructured":"Malcolm CE, Cumming DC: Does anovulation exist in eumenorrheic women?. Obstet Gynecol. 2003, 102: 317-318. 10.1016\/S0029-7844(03)00527-1.","journal-title":"Obstet Gynecol"},{"key":"920_CR32","first-page":"354","volume":"37","author":"A Mehta","year":"1992","unstructured":"Mehta A, Matwijiw I, Taylor PJ, Salamon EA, Kredentser JV, Faiman C: Should androgen levels be measured in hirsute women with normal menstrual cycles?. Int J Fertil. 1992, 37: 354-357.","journal-title":"Int J Fertil"},{"key":"920_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1023\/A:1023606524944","volume":"18","author":"F Azizi","year":"2003","unstructured":"Azizi F, Rahmani M, Ghanbarian A, Emami H, Salehi P, Mirmiran P, Sarbazi N: Serum lipid levels in an Iranian adults population: Tehran Lipid and Glucose Study. Eur J Epidemiol. 2003, 18: 311-319.","journal-title":"Eur J Epidemiol"},{"key":"920_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1001\/jama.1968.03140060001001","volume":"203","author":"L Chiazze Jr","year":"1968","unstructured":"Chiazze L, Brayer FT, Macisco JJ, Parker MP, Duffy BJ: The length and variability of the human menstrual cycle. JAMA. 1968, 203: 377-380. 10.1001\/jama.203.6.377.","journal-title":"JAMA"},{"key":"920_CR35","first-page":"77","volume":"12","author":"AE Treloar","year":"1967","unstructured":"Treloar AE, Boynton RE, Behn BG, Brown BW: Variation of the human menstrual cycle through reproductive life. Int J Fertil. 1967, 12: 77-126.","journal-title":"Int J Fertil"},{"key":"920_CR36","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S1472-6483(10)61644-6","volume":"8","author":"R Azziz","year":"2004","unstructured":"Azziz R: PCOS: a diagnostic challenge. Reprod Biomed Online. 2004, 8: 644-648. 10.1016\/S1472-6483(10)61644-6.","journal-title":"Reprod Biomed Online"},{"key":"920_CR37","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1365-2265.2007.02932.x","volume":"67","author":"JH Barth","year":"2007","unstructured":"Barth JH, Yasmin E, Balen AH: The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research. Clin Endocrinol (Oxf). 2007, 67: 811-815. 10.1111\/j.1365-2265.2007.02932.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"920_CR38","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/j.1471-0528.2006.01008.x","volume":"113","author":"FJ Broekmans","year":"2006","unstructured":"Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC: PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG. 2006, 113: 1210-1217. 10.1111\/j.1471-0528.2006.01008.x.","journal-title":"BJOG"},{"key":"920_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/09513598709023610","volume":"1","author":"MG Hull","year":"1987","unstructured":"Hull MG: Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol. 1987, 1: 235-245. 10.3109\/09513598709023610.","journal-title":"Gynecol Endocrinol"},{"key":"920_CR40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1365-2265.2002.01603.x","volume":"57","author":"CN Wijeyaratne","year":"2002","unstructured":"Wijeyaratne CN, Balen AH, Barth JH, Belchetz PE: Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?. Clin Endocrinol (Oxf). 2002, 57: 343-350. 10.1046\/j.1365-2265.2002.01603.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"920_CR41","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1530\/eje.0.1390421","volume":"139","author":"E Carmina","year":"1998","unstructured":"Carmina E: Prevalence of idiopathic hirsutism. Eur J Endocrinol. 1998, 139: 421-423. 10.1530\/eje.0.1390421.","journal-title":"Eur J Endocrinol"},{"key":"920_CR42","first-page":"311","volume":"25","author":"C Moran","year":"1994","unstructured":"Moran C, Tapia MC, Hernandez E, Vazquez G, Garcia-Hernandez E, Bermudez JA: Etiological review of hirsutism in 250 patients. Arch Med Res. 1994, 25: 311-314.","journal-title":"Arch Med Res"},{"key":"920_CR43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1210\/jc.2005-1457","volume":"91","author":"E Carmina","year":"2006","unstructured":"Carmina E, Rosato F, Janni A, Rizzo M, Longo RA: Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab. 2006, 91: 2-6. 10.1210\/jc.2005-1457.","journal-title":"J Clin Endocrinol Metab"},{"key":"920_CR44","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1210\/jc.2005-2153","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R: Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab. 2006, 91: 781-785.","journal-title":"J Clin Endocrinol Metab"},{"key":"920_CR45","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.fertnstert.2006.11.012","volume":"87","author":"LA Wise","year":"2007","unstructured":"Wise LA, Palmer JR, Stewart EA, Rosenberg L: Polycystic ovary syndrome and risk of uterine leiomyomata. Fertil Steril. 2007, 87: 1108-1115. 10.1016\/j.fertnstert.2006.11.012.","journal-title":"Fertil Steril"},{"key":"920_CR46","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)54892-4","volume":"57","author":"E Dahlgren","year":"1992","unstructured":"Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Oden A, Janson PO, Mattson LA, Crona N, Lundberg PA: Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril. 1992, 57: 505-513.","journal-title":"Fertil Steril"},{"key":"920_CR47","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1210\/jc.2003-030932","volume":"89","author":"JS Laven","year":"2004","unstructured":"Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC: Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004, 89: 318-323. 10.1210\/jc.2003-030932.","journal-title":"J Clin Endocrinol Metab"},{"key":"920_CR48","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.maturitas.2004.02.006","volume":"49","author":"K Mohammad","year":"2004","unstructured":"Mohammad K, Sadat Hashemi SM, Farahani FK: Age at natural menopause in Iran. Maturitas. 2004, 49: 321-326. 10.1016\/j.maturitas.2004.02.006.","journal-title":"Maturitas"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7827-9-144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T17:14:38Z","timestamp":1630516478000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/1477-7827-9-144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["920"],"URL":"https:\/\/doi.org\/10.1186\/1477-7827-9-144","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,1]]},"assertion":[{"value":"17 August 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"144"}}